Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recent trends of Japanese hepatocellular carcinoma due to HCV in aging society.
Hiraoka A, Hidaka S, Shimizu Y, Utsunomiya H, Imai Y, Tatsukawa H, Tazuya N, Yamago H, Yorimitsu N, Tanihira T, Hasebe A, Miyamoto Y, Ninomiya T, Kawasaki H, Hirooka M, Abe M, Hiasa Y, Matsuura B, Onji M, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Hepatogastroenterology. 2012 Sep;59(118):1893-5. doi: 10.5754/hge11732. Hepatogastroenterology. 2012. PMID: 22193439
Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications.
Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi K, Yamamoto Y, Hasebe A, Ichikawa S, Yano M, Miyamoto Y, Ninomiya T, Otomi Y, Kokame M, Iwamura T, Ishimaru Y, Sogabe I, Kashihara K, Nishiura S, Ootani H, Takamura K, Kawasaki H. Hiraoka A, et al. Among authors: kawasaki h. Hepatogastroenterology. 2008 Nov-Dec;55(88):2171-4. Hepatogastroenterology. 2008. PMID: 19260499
Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi H, Yamamoto Y, Ichikawa S, Hasebe A, Yano M, Miyamoto Y, Ninomiya T, Ootani H, Takamura K, Kawasaki H, Otomi Y, Kogame M, Sogabe I, Ishimaru Y, Kashihara K, Miyagawa M, Hirooka M, Hiasa Y, Matsuura B, Michitaka K, Onji M. Hiraoka A, et al. Among authors: kawasaki h. Hepatogastroenterology. 2009 Jan-Feb;56(89):213-7. Hepatogastroenterology. 2009. PMID: 19453060
Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients.
Hiraoka A, Michitaka K, Horiike N, Hidaka S, Uehara T, Ichikawa S, Hasebe A, Miyamoto Y, Ninomiya T, Sogabe I, Ishimaru Y, Kawasaki H, Koizumi Y, Hirooka M, Yamashita Y, Abe M, Hiasa Y, Matsuura B, Onji M. Hiraoka A, et al. Among authors: kawasaki h. J Gastroenterol Hepatol. 2010 Feb;25(2):403-7. doi: 10.1111/j.1440-1746.2009.06037.x. Epub 2009 Nov 19. J Gastroenterol Hepatol. 2010. PMID: 19929922
Hepatic resection assisted by ablative therapy for advanced hepatocellular carcinoma.
Hiraoka A, Tazuya N, Hidaka S, Uehara T, Ichiryu M, Nakahara M, Tanabe A, Shimizu Y, Tanihira T, Hasebe A, Miyamoto Y, Ninomiya T, Kawasaki H, Ochi H, Koizumi Y, Hirooka M, Abe M, Hiasa Y, Matsuura B, Onji M, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Hepatogastroenterology. 2011 May-Jun;58(107-108):955-9. Hepatogastroenterology. 2011. PMID: 21830423
Importance of screening for synchronous malignant neoplasms in patients with hepatocellular carcinoma: impact of FDG PET/CT.
Hiraoka A, Hirooka M, Ochi H, Koizumi Y, Shimizu Y, Shiraishi A, Yamago H, Tanihira T, Miyata H, Ninomiya T, Kawasaki H, Ishimaru Y, Sogabe I, Inoue T, Abe M, Hiasa Y, Matsuura B, Onji M, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Liver Int. 2013 Aug;33(7):1085-91. doi: 10.1111/liv.12161. Epub 2013 Apr 18. Liver Int. 2013. PMID: 23601196
Prognosis and therapy for ruptured hepatocellular carcinoma: problems with staging and treatment strategy.
Hiraoka A, Kawamura T, Aibiki T, Okudaira T, Toshimori A, Yamago H, Nakahara H, Suga Y, Azemoto N, Miyata H, Miyamoto Y, Ninomiya T, Murakami T, Ishimaru Y, Kawasaki H, Hirooka M, Abe M, Matsuura B, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Eur J Radiol. 2015 Mar;84(3):366-371. doi: 10.1016/j.ejrad.2014.11.038. Epub 2014 Dec 15. Eur J Radiol. 2015. PMID: 25554005
Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
Hiraoka A, Ishimaru Y, Kawasaki H, Aibiki T, Okudaira T, Toshimori A, Kawamura T, Yamago H, Nakahara H, Suga Y, Azemoto N, Miyata H, Miyamoto Y, Ninomiya T, Hirooka M, Abe M, Matsuura B, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: kawasaki h. Oncology. 2015;89(3):167-74. doi: 10.1159/000381808. Epub 2015 May 12. Oncology. 2015. PMID: 25999038
Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Ueki H, Kaneto M, Aibiki T, Okudaira T, Kawakami T, Kawamura T, Yamago H, Suga Y, Miyamoto Y, Tomida H, Azemoto N, Mori K, Miyata H, Ninomiya T, Kawasaki H. Hiraoka A, et al. Among authors: kawasaki h. J Gastroenterol Hepatol. 2016 May;31(5):1031-6. doi: 10.1111/jgh.13250. J Gastroenterol Hepatol. 2016. PMID: 26647219
2,364 results